Takeda India employees celebrating Great Place To Work certification

Takeda Biopharmaceuticals India Private Limited, formerly known as Baxalta Bioscience India Pvt. Ltd., has earned the Great Place To Work® certification in India for the period between March 2023 and March 2024. The R&D-driven global biopharmaceutical company specializes in four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).

The Great Place To Work® Institute, the worldwide authority on workplace culture, has identified the key characteristics of outstanding workplaces, including strong leadership, consistent employee experience, and stable financial performance. The Institute partners with more than 1400 organizations across 22 industries in India, helping them develop High-Trust, High-Performance Cultures.

Takeda’s employees work diligently to improve the quality of life for patients and collaborate with healthcare partners across nearly 80 countries and regions. The Great Place to Work® certification in India acknowledges Takeda’s commitment to creating a culture that values employee well-being, professional development, and the organization’s mission and values.

Author

By